V up +0.94% percent right now. $V High is at 252.43 and the

New Post Public Reply Private Reply Replies (0) Message Board
Lucky Jimmy
V up +0.94% percent right now. $V High is at 252.43 and the Low 249.04 with current volume of 2,374,900.

Recent News posted below.

V Visa Inc Recent Headline News

3 Mistakes Smart Investors Never Make
Motley Fool Staff, Matthew Frankel, Jordan Wathen, and Cheryl Swanson - Motley Fool - 1 hr 35 mins ago
What makes the best investors so successful? It's not so much a matter of always picking the big winners, but having a set of knowledge and good investing habits that can make all the difference over the long run. With that in mind, we asked three of...
V: 252.43 (+2.34), MCD: 95.10 (+0.44), MAR: 75.50 (+0.25), MA: 84.80 (-0.95)

Final Glance: Credit Card companies
AP - Fri Nov 07, 5:08PM CST
NEW YORK (AP) — Shares of some top credit card companies were mixed at the close of trading:
DFS: 66.03 (+0.34), V: 252.43 (+2.34), COF: 82.60 (+0.52), AXP: 92.26 (+0.68)

Dow Jones (DJIA) Today: Visa (V) Leads The Day Higher, Nike (NKE) Lags
at The Street - Fri Nov 07, 3:30PM CST
The Dow component that led the way higher today was Visa (NYSE:V), which sported a $2.34 gain (+0.9%) bringing the stock to $252.43. Holding the Dow back today was Nike (NYSE:NKE), which lagged the broader Dow index with an 86-cent decline (-0.9%)...
V: 252.43 (+2.34), NKE: 93.78 (-0.82)

Midday Glance: Credit Card companies
AP - Fri Nov 07, 12:18PM CST
NEW YORK (AP) — Shares of some top credit card companies are mixed at 1 p.m.:
DFS: 66.03 (+0.34), V: 252.43 (+2.34), COF: 82.60 (+0.52), AXP: 92.26 (+0.68)

Stock Indexes Try To Rebound; Disney Hit Hard
at Investor's Business Daily - Fri Nov 07, 10:46AM CST
Stocks struggled to overcome early weakness as the indexes approached the midday mark. The Nasdaq was off 0.2% after being down as much as 0.7%. The S&P 500 inched up 0.1%, while the Dow Jones industrial average was just barely positive. Volume in...
V: 252.43 (+2.34), AXP: 92.26 (+0.68), DIS: 90.00 (-2.00)

Early Glance: Credit Card companies
AP - Fri Nov 07, 9:53AM CST
NEW YORK (AP) — Shares of some top credit card companies are mixed at 10 a.m.:
DFS: 66.03 (+0.34), V: 252.43 (+2.34), COF: 82.60 (+0.52), AXP: 92.26 (+0.68)

Upcoming Investor Conferences, Survey Results, Corporate Statement, and Third Quarter Results - Research Reports on Visa, Simon, Goldman Sachs, ARCP and Umpqua
PR Newswire - Fri Nov 07, 8:20AM CST
Today, Analysts Review released its research reports regarding Visa Inc. (NYSE: V), Simon Property Group Inc. (NYSE: SPG), The Goldman Sachs Group, Inc. (NYSE: GS), American Realty Capital Properties, Inc. (NASDAQ: ARCP) and Umpqua Holdings Corporation (NASDAQ: UMPQ). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7793-100free.
UMPQ: 17.78 (+0.13), RCAP: 11.32 (+0.35), GS: 190.71 (-0.29), V: 252.43 (+2.34), SPG: 179.44 (-0.64), ARCP: 8.79 (+0.15)

Discover Financial Services Is Jilted by Apple, but Don't Give Up on Discover Yet
at The Street - Fri Nov 07, 5:10AM CST
Discover isn't part of Apple Pay -- but there just may be a better life outside of Apple's system and in another mobile payments platform.
BCS: 14.91 (-0.10), DFS: 66.03 (+0.34), V: 252.43 (+2.34), AXP: 92.26 (+0.68), WMT: 78.77 (+0.96), CVS: 88.38 (-0.05), BBY: 35.18 (-0.03), AAPL: 109.01 (+0.31), MA: 84.80 (-0.95)

Dow Jones (DJIA) Today: Visa (V) Higher
at The Street - Thu Nov 06, 1:00PM CST
The Dow component leading the way higher looks to be Visa (NYSE:V), which is sporting a 32-cent gain (+0.1%) bringing the stock to $249.85.
V: 252.43 (+2.34)

Vendini Joins PCI Security Standards Council to Improve Payment Data Security Worldwide, Hires Former PG&E Security Lead to Innovate Security Techniques
Marketwired - Thu Nov 06, 11:10AM CST
Today, Vendini, the company that makes the business of live events simple, announced that it has joined the PCI Security Standards Council as a new Participating Organization. Vendini will work with the Council to achieve and improve payment data security worldwide through the ongoing development of the PCI Security Standards, including the Payment Card Industry Data Security Standard (PCI DSS), PIN Transaction Security (PTS) requirements and the Payment Application Data Security Standard (PA-DSS).
V: 252.43 (+2.34)

Visa Announces Strategic Community Partners for a "Healthy & Vibrant" San Francisco
Business Wire - Thu Nov 06, 11:00AM CST
Visa Inc. (NYSE:V), the global leader in payments, today announced the company's commitment to a "Healthy & Vibrant" San Francisco, including collaboration with five strategic community partner organizations. Beginning with $500,000 in philanthropic support for specific programs as well as ongoing employee volunteerism, the company will work with these key non-profit organizations in their efforts to create economic opportunity, serve youth, provide food security, support green neighborhoods and respond in times of emergency in San Francisco.
V: 252.43 (+2.34)

Apple Pay Will Be a Game Changer But It'll Take Awhile To Get There: Study
at The Street - Thu Nov 06, 9:52AM CST
New research predicts Apple's swipe payment system will be a big success but could take a many years for it to catch on.
AXP: 92.26 (+0.68), WMT: 78.77 (+0.96), M: 59.88 (+0.84), GOOG: 541.01 (-1.03), LUV: 38.24 (+0.30), RAD: 5.41 (+0.06), V: 252.43 (+2.34), EBAY: 53.51 (+0.25), TGT: 64.17 (+2.28), CVS: 88.38 (-0.05), MCD: 95.10 (+0.44), AAPL: 109.01 (+0.31), WAG: 66.92 (+0.27), MA: 84.80 (-0.95)

Visa Up 16.9% Since SmarTrend Uptrend Call (V)
Comtex SmarTrend(R) - Thu Nov 06, 9:20AM CST
SmarTrend identified an Uptrend for Visa (NYSE:V) on October 22nd, 2014 at $212.36. In approximately 2 weeks, Visa has returned 16.90% as of today's recent price of $248.24.
V: 252.43 (+2.34)

Stock Futures Shed Losses, Rise; Sierra Wireless, Tableau Rocket
at Investor's Business Daily - Thu Nov 06, 7:58AM CST
Stock futures reversed early losses to point firmly higher ahead of Thursday's open. Dow futures sloughed off a 26-point decline and were up 26.5 points. Nasdaq 100 futures backed out of a 10-point loss to trade 4.2 points above fair market value....
TSLA: 240.20 (-1.02), SWIR: 33.90 (+0.30), V: 252.43 (+2.34), AXP: 92.26 (+0.68), MRK: 59.34 (+0.08), DATA: 84.92 (+0.63), CSCO: 25.33 (+0.07)

3 Things MasterCard Inc. Management Wants You to Know
Jordan Wathen, The Motley Fool - Motley Fool - Thu Nov 06, 7:01AM CST
MasterCard is a relatively simple business that boils down to two metrics: transaction volume and average fees. But some small nuances are best understood with the insight of the management team. Here are three things MasterCard executives...
V: 252.43 (+2.34), MA: 84.80 (-0.95)

Mobile Adoption Drives Online Payments, Security - Zacks Analyst Interviews
Sejuti Banerjea - Zacks Investment Research - Thu Nov 06, 4:03AM CST
Mobile Adoption Drives Online Payments, Security - Zacks Analyst Interviews
AMZN: 299.86 (+3.22), FIS: 58.38 (-0.54), BBRY: 10.53 (+0.26), SYMC: 24.97 (-0.10), JNPR: 21.91 (+0.30), V: 252.43 (+2.34), EBAY: 53.51 (+0.25), IBM: 162.07 (+0.61), GOOGL: 551.82 (+0.13), MSFT: 48.68 (-0.02), AAPL: 109.01 (+0.31), MA: 84.80 (-0.95), CSCO: 25.33 (+0.07), CHKP: 74.67 (+0.16)

Mobile Adoption Drives Online Payments, Security - Industry Outlook
Sejuti Banerjea - Zacks Investment Research - Thu Nov 06, 4:03AM CST
Mobile Adoption Drives Online Payments, Security - Industry Outlook
AMZN: 299.86 (+3.22), FIS: 58.38 (-0.54), BBRY: 10.53 (+0.26), SYMC: 24.97 (-0.10), JNPR: 21.91 (+0.30), V: 252.43 (+2.34), EBAY: 53.51 (+0.25), IBM: 162.07 (+0.61), GOOGL: 551.82 (+0.13), MSFT: 48.68 (-0.02), AAPL: 109.01 (+0.31), MA: 84.80 (-0.95), CSCO: 25.33 (+0.07), CHKP: 74.67 (+0.16)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 6

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 3

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 12

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
More News Articles